Short Summary
In-House Lab combines diagnostic services with very different cost structures. Manual diagnostics rely mainly on professional time and low-cost supplies. Point-of-care tests consume single-use kits. Analyzer diagnostics depend on reagents, controls, consumables, equipment arrangements, and utilization. A single blended account cannot show which modality changed or why.
The recommended practice is to maintain three matched revenue and COGS streams inside the practice's PIMS and accounting system. The supplemental accounts preserve the standard In-House Lab roll-up for external reporting while giving leaders enough detail to follow each modality over time and compare matching work across affiliated practices.
Business Issue
A blended In-House Lab COGS percentage is mathematically correct but often incomplete for management. Two practices can use the same PIMS, charge the same client fees, receive the same vendor unit pricing, and still report very different totals because their diagnostic mix, utilization, waste, reruns, and inventory controls differ.
The same problem appears in group benchmarking. In one veterinary management group composed of practices owned by several different owners, blended In-House Lab COGS ranged from 5.5% to 58.3%. Manual diagnostics represented 3.2% to 76.3% of In-House Lab revenue among practices with PIMS detail. Comparing those totals as though they describe the same work can lead to the wrong conclusion about pricing, purchasing, or operating discipline.
Why It Matters
A low blended percentage may reflect a large amount of manual diagnostic revenue rather than superior purchasing.
A high blended percentage may reflect a larger concentration of kit-based or analyzer testing rather than weak management.
Identical unit pricing can still produce different realized COGS because of expired tests, uncharged reruns, waste, inventory control, and timing differences between purchases and use.
Misclassifying tests between In-House Lab and Outside Lab changes both category ratios and obscures the operating model.
Separating revenue without separating the matching direct costs creates another incomplete ratio.
VizVet Implementation Assistance
VizVet can assist with implementation when VizVet has access to the practice's PIMS data. VizVet can review the complete In-House Lab service and inventory-item list, propose the appropriate diagnostic category and supplemental GL mapping for each item, identify exceptions that require clinical or accounting review, and prepare the working file used to update the PIMS and accounting mappings. The practice's authorized leaders approve the classifications and system changes.
Governing Definitions
Classify each diagnostic item according to the methodology used to perform the test, not the medical purpose of the test. The same medical question may belong to different accounts when one practice uses a rapid kit and another uses analyzer-based instrumentation.
Diagnostic modality | Matched accounts | Definition | Representative examples |
|---|---|---|---|
Manual In-House Diagnostics | 5311 revenue | Procedures performed and interpreted by practice team members using microscopy or direct examination with minimal laboratory equipment or consumable testing devices. | Ear and skin cytology, FNA cytology, fecal microscopy, microscopic urinalysis, blood smears, PCV / total solids, skin scrapings |
Point-of-Care Testing | 5312 revenue | Rapid tests performed by practice team members using single-use kits, ELISA-based assays, lateral-flow devices, cartridges, cassettes, or similar consumable technologies. | Antigen, antibody, combination, endocrine, coagulation, and other rapid immunoassay tests |
In-House Analyzer Diagnostics | 5313 revenue | Testing performed by practice team members using automated or semi-automated analyzers owned or operated by the practice. | CBC, chemistry, electrolytes, automated urinalysis, blood gas, analyzer-based coagulation, AI-assisted cytology |
Matched direct costs
6311 includes slides, stains, collection containers, needles, syringes, and other supplies used specifically for manual diagnostic evaluation.
6312 includes rapid test kits, cartridges, cassettes, ELISA-based assays, lateral-flow devices, and similar POCT consumables.
6313 includes analyzer reagents, calibrators, controls, analyzer consumables, and related direct supplies.
Specimen collection follows the test
Revenue and direct supplies associated with specimen collection follow the related diagnostic method. Phlebotomy, cystocentesis, fine needle aspiration, and skin scraping should not be separated from the diagnostic stream they support when performed specifically to obtain the specimen for that test.
In-house versus outside laboratory
Classify a test as in-house when the diagnostic work is performed within the practice. Classify it as Outside Lab when an external laboratory performs the diagnostic service. A familiar test name does not determine the account. For example, a 4Dx test performed in the hospital remains in-house even if similar testing is also available from a reference laboratory.
Recommended Management Structure
1. Create matched account pairs. Use 5311–5313 for revenue and 6311–6313 for the related direct costs. Do not implement the revenue detail without the corresponding COGS structure.
2. Preserve the standard roll-up. The VizVet Supplemental In-House Lab revenue accounts 5311, 5312, and 5313 roll up to 5301 In-House Lab Revenue. The corresponding COGS accounts 6311, 6312, and 6313 roll up to 6301 In-House Lab COGS for Datalink and other external reporting. This preserves the standard parent-account structure while retaining the additional management detail.
3. Apply one classification rule. Use test methodology consistently across every practice. Document ambiguous items rather than allowing each location, bookkeeper, or PIMS user to make an independent decision.
4. Align PIMS and accounting mappings. The PIMS determines where service and inventory-item revenue is classified. QuickBooks determines where vendor purchases and other direct costs are recorded. Both systems must describe the same diagnostic modality.
5. Reconcile before interpreting. Confirm that the three revenue accounts sum to the consolidated In-House Lab total and that the three COGS accounts sum to consolidated In-House Lab COGS before analyzing trends or comparing practices.
Recommended Operating Rhythm
Cadence | Management control | Expected output |
|---|---|---|
Initial design | Approve the definitions, account hierarchy, roll-up behavior, and decision owners. | One governing classification standard |
PIMS setup | Assign every active In-House Lab service and inventory item to 5311, 5312, or 5313. | Complete revenue mapping with documented exceptions |
Accounting setup | Create 6311, 6312, and 6313 and map vendors, products, and recurring entries to the matching cost stream. | Matched direct-cost structure |
Monthly | Reconcile supplemental accounts to 5301 and 6301; review new items, unmapped activity, credits, and missing costs. | Reliable monthly modality totals |
Quarterly | Review COGS trends by modality and investigate changes in mix, pricing, expiration, reruns, waste, utilization, and inventory control. | Documented explanations and actions |
Annual or when operations change | Review analyzer platforms, test menus, vendor arrangements, definitions, mappings, and account ownership. | Current classification and governance |
Comparison and Benchmarking Rules
Use the consolidated total for the right purpose
The standard In-House Lab total remains useful for following each practice's own trend and for required external roll-up reporting. It should not be used by itself to compare practices because it combines different proportions of manual, POCT, and analyzer work.
Compare matching modalities
Cross-practice comparison becomes more reliable after every location uses the same definitions, maps both revenue and cost, and reconciles the supplemental accounts. Leaders can then compare manual diagnostics with manual diagnostics, POCT with POCT, and analyzer diagnostics with analyzer diagnostics.
Check comparability before using a benchmark
Exclude or clearly flag periods with missing revenue or missing COGS.
Identify quarterly revenue booking, pooled revenue, credits, and costs recorded in a later period.
Resolve in-house tests mapped to Outside Lab and external tests mapped to In-House Lab.
Confirm that the numerator and denominator cover the same activity and time period.
Use both pooled cohort results and practice-level distributions; one measure can conceal outliers or mix differences.
Practical Example
One practice in that management group reported In-House Lab COGS of 5.5%. Manual diagnostics represented 76.3% of its In-House Lab revenue. Removing that revenue from the denominator increased the calculated ratio to 23.1%. The original ratio was not false, but it answered a different question because it blended manual work with kit-based and analyzer diagnostics.
At the cohort level, In-House Lab COGS increased from 22.4% to 24.8% after manual diagnostic revenue was excluded. The average effect was meaningful, but individual practices moved very differently. That is why the practice should preserve its own trend while using modality-level detail for like-for-like comparison.
Roles and Ownership
Role | Responsibility |
|---|---|
Executive sponsor or owner | Approves the management objective, account structure, implementation resources, and cross-practice standard. |
Practice manager or PIMS administrator | Maintains service and inventory-item mappings and identifies new or ambiguous items. |
Clinical lead | Confirms how tests are performed and resolves methodology questions that item names alone cannot answer. |
Bookkeeper or finance team | Creates and maintains the supplemental accounts, maps purchases, and investigates unmatched or missing costs. |
Analyst or VizVet reviewer | Tests reconciliation, monitors trends, evaluates comparability, and separates mix effects from operating questions. |
Common Problems This Prevents
Classifying a test by its medical purpose instead of how the test is performed.
Splitting revenue into three categories while leaving all purchases in one COGS account.
Treating a low blended COGS percentage as evidence of superior purchasing without reviewing manual diagnostic mix.
Treating a high blended percentage as weak management without reviewing POCT and analyzer concentration.
Allowing expired tests, uncharged reruns, waste, or inventory losses to remain hidden in the total.
Comparing practices when revenue and cost periods, mappings, or account completeness differ.
Creating VizVet Supplemental accounts that do not roll up to the standard 5301 and 6301 parent accounts used for Datalink and other external reporting.
Decision Benefit
The three-category structure makes the consolidated In-House Lab result explainable. Leaders can determine whether a change comes from diagnostic mix, client pricing, unit cost, expiration, reruns, waste, inventory control, analyzer utilization, or classification. Multi-practice owners can also identify whether locations follow the same operating and pricing standards without assuming that every hospital should have the same blended percentage.
For step-by-step system changes, use the companion In-House Lab Implementation Guide.
This resource supports management reporting. It is not legal, tax, audit, or formal accounting advice. Practices should coordinate material financial-statement and tax-reporting decisions with their qualified advisors.
Related Resources
VizVet Insight: Understanding the Three Types of In-House Lab Diagnostics
Implementation Guide: In-House Lab PIMS and Accounting Implementation Checklist
Case Study: Two Affiliated Practices with Different In-House Lab COGS
Case Study: Diagnostic Mix Changes In-House Lab Benchmark Comparability
VizVet Supplemental GL Account Definitions